Valerie A Smith1,2,3, Matthew L Maciejewski1,2,3, Theodore S Z Berkowitz1, James E Mitchell4,5, Chuan-Fen Liu6, Katharine A Bradley5,7,8, Maren K Olsen1,9, Edward L Livingston10, David E Arterburn5,7. 1. Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham VA Medical Center, Durham, NC. 2. Department of Population Health Sciences, Duke University, Durham, NC. 3. Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC. 4. University of North Dakota School of Medicine and Health Sciences, Fargo, ND. 5. Kaiser Permanente Washington Health Research Institute, Seattle, WA. 6. Health Services Research & Development Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, WA. 7. Department of Medicine, University of Washington, Seattle, WA. 8. Department of Health Services, University of Washington, Seattle, WA. 9. Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. 10. Department of Surgery, University of California at Los Angeles, Los Angeles, CA.
Abstract
OBJECTIVE: In a large multisite cohort of Veterans who underwent Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (LSG), initiation of (ie, incident) and persistence of (ie, continuation of preoperative) depression treatment are compared with matched nonsurgical controls. BACKGROUND: Bariatric surgery has been associated with short-term improvements in depression but less is known about longer term outcomes. METHODS: In a retrospective cohort study, we matched 1713 Veterans with depression treatment who underwent bariatric surgery in Veterans Administration bariatric centers from fiscal year 2001 to 2016 to 15,056 nonsurgical controls using sequential stratification and examined the persistence of depression treatment via generalized estimating equations. Incidence of depression treatment was compared using Cox regression models between 2227 surgical patients and 20,939 matched nonsurgical controls without depression treatment at baseline. RESULTS: In surgical patients with depression treatment at baseline, the use of postsurgical depression treatment declined over time for both surgical procedures, but postsurgical patients had greater use of depression treatment at 5 years [RYGB: odds ratio=1.24, 95% confidence interval (CI): 1.04-1.49; LSG: odds ratio=1.27, 95% CI: 1.04-1.56] compared with controls. Among those without depression treatment at baseline, bariatric surgery was associated with a higher incidence of depression treatment compared with matched controls (RYGB: hazard ratio=1.34, 95% CI: 1.17-1.53; LSG: hazard ratio at 1-5 years=1.27, 95% CI: 1.10-1.47). CONCLUSIONS: Bariatric surgery was associated with a greater risk of postoperative incident depression treatment and greater persistence of postoperative depression treatment. Depression may worsen for some patients after bariatric surgery, so clinicians should carefully monitor their patients for depression postoperatively.
OBJECTIVE: In a large multisite cohort of Veterans who underwent Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (LSG), initiation of (ie, incident) and persistence of (ie, continuation of preoperative) depression treatment are compared with matched nonsurgical controls. BACKGROUND: Bariatric surgery has been associated with short-term improvements in depression but less is known about longer term outcomes. METHODS: In a retrospective cohort study, we matched 1713 Veterans with depression treatment who underwent bariatric surgery in Veterans Administration bariatric centers from fiscal year 2001 to 2016 to 15,056 nonsurgical controls using sequential stratification and examined the persistence of depression treatment via generalized estimating equations. Incidence of depression treatment was compared using Cox regression models between 2227 surgical patients and 20,939 matched nonsurgical controls without depression treatment at baseline. RESULTS: In surgical patients with depression treatment at baseline, the use of postsurgical depression treatment declined over time for both surgical procedures, but postsurgical patients had greater use of depression treatment at 5 years [RYGB: odds ratio=1.24, 95% confidence interval (CI): 1.04-1.49; LSG: odds ratio=1.27, 95% CI: 1.04-1.56] compared with controls. Among those without depression treatment at baseline, bariatric surgery was associated with a higher incidence of depression treatment compared with matched controls (RYGB: hazard ratio=1.34, 95% CI: 1.17-1.53; LSG: hazard ratio at 1-5 years=1.27, 95% CI: 1.10-1.47). CONCLUSIONS: Bariatric surgery was associated with a greater risk of postoperative incident depression treatment and greater persistence of postoperative depression treatment. Depression may worsen for some patients after bariatric surgery, so clinicians should carefully monitor their patients for depression postoperatively.
Authors: Hartej Gill; Barjot Gill; Sabine El-Halabi; David Chen-Li; Orly Lipsitz; Joshua Daniel Rosenblat; Tamsyn E Van Rheenen; Nelson B Rodrigues; Rodrigo B Mansur; Amna Majeed; Leanna M W Lui; Flora Nasri; Yena Lee; Roger S Mcintyre Journal: Obesity (Silver Spring) Date: 2020-10-06 Impact factor: 5.002
Authors: Helen Booth; Omar Khan; A Toby Prevost; Marcus Reddy; Judith Charlton; Martin C Gulliford Journal: J Affect Disord Date: 2014-12-29 Impact factor: 4.839
Authors: Jodi B Segal; Jeanne M Clark; Andrew D Shore; Francesca Dominici; Thomas Magnuson; Thomas M Richards; Jonathan P Weiner; Eric B Bass; Albert W Wu; Martin A Makary Journal: Obes Surg Date: 2009-12 Impact factor: 4.129
Authors: James E Mitchell; Wendy C King; Jia-Yuh Chen; Michael J Devlin; David Flum; Luis Garcia; William Inabet; John R Pender; Melissa A Kalarchian; Saurabh Khandelwal; Marsha D Marcus; Beth Schrope; Gladys Strain; Bruce Wolfe; Susan Yanovski Journal: Obesity (Silver Spring) Date: 2014-03-25 Impact factor: 5.002
Authors: Ali Aminian; Sangeeta R Kashyap; Kathy E Wolski; Stacy A Brethauer; John P Kirwan; Steven E Nissen; Deepak L Bhatt; Philip R Schauer Journal: Ann Surg Date: 2021-09-01 Impact factor: 13.787